How to Find Hemgenix in Stock Near You (Tools + Tips for 2026)

Finding Hemgenix in stock in 2026 is not like tracking down a common medication at a local pharmacy. Hemgenix (etranacogene dezaparvovec-drlb) is a one-time gene therapy for hemophilia B that is only available through certified hemophilia treatment centers (HTCs) — and as of March 2026, CSL Behring has announced a temporary global stockout. That said, supply situations can vary by region and individual center, and some patients may still be able to access treatment with the right approach.

Here is everything you need to know about finding Hemgenix, from understanding how it is distributed to practical steps for tracking down available supply.

Step 1: Understand How Hemgenix Is Distributed

Hemgenix is classified as a limited-distribution drug. It is not stocked at CVS, Walgreens, or any retail pharmacy. Instead, it is shipped directly from CSL Behring to certified hemophilia treatment centers and qualified infusion facilities. These centers are required to have specialized training, emergency response capabilities, and the ability to perform the mandatory pre- and post-infusion monitoring (including weekly liver function tests for 3 months post-dose).

Each patient's kit is weight-specific — a 126–130 kg patient receives a different kit than a 70 kg patient — because dosing is calculated as 2 × 10¹³ genome copies per kilogram (2 mL/kg). This custom preparation adds another layer of logistics that makes traditional pharmacy stocking impossible.

Step 2: Find a Certified Hemgenix Treatment Center

The HEMGENIX Connect patient support program offers a treatment center locator. By entering your ZIP code on the HEMGENIX website or calling 1-833-436-0021 (M–F 8AM–8PM ET), you can identify the closest certified administration center. The HEMGENIX Connect program also assigns you a dedicated Case Manager and Patient Resource Navigator who can help coordinate care.

Additional resources to find a center:

National Hemophilia Foundation (NHF): The NHF maintains a directory of federally funded hemophilia treatment centers across the U.S. Visit hog.org or call 1-800-42-HANDI.

CDC Hemophilia Treatment Center network: The CDC funds 140+ HTCs across the U.S., many of which are qualified Hemgenix administration sites.

Children's Hospital Los Angeles (CHLA): CHLA is one of the few West Coast centers certified to administer Hemgenix and played a role in the clinical trials.

Step 3: Check the Current Supply Situation at Multiple Centers

During the 2026 global stockout, supply availability varies. Some treatment centers may have already taken delivery of their ordered kits; others may be waiting. The most reliable way to know the current situation is to contact centers directly — or to use a service that does it for you.

medfinder is a paid service that contacts specialty pharmacies and treatment facilities on your behalf to find out which ones have Hemgenix available. You enter your medication and location, medfinder makes the calls, and you receive the results by text — saving you hours of phone work.

Step 4: Complete the Pre-Treatment Eligibility Process Early

Even if Hemgenix supply in your area is temporarily limited, use the waiting period to complete the pre-treatment workup so you are ready the moment supply becomes available. Required tests include:

Factor IX inhibitor screening (negative results required; retest if initially positive)

Baseline liver function tests (ALT, AST) and liver ultrasound

Hepatitis B and C screening

AAV5 neutralizing antibody test (CSL Behring provides and covers cost of this test)

Vaccinations up to date (as applicable)

Getting these completed in advance means you can receive treatment without additional delay once supply is confirmed.

Step 5: Start the Insurance Prior Authorization Process Now

Insurance approval for Hemgenix typically takes 2–4 weeks and is covered under your medical benefit (not pharmacy benefit). Most commercially insured patients qualify for $0 out-of-pocket cost through CSL Behring's Copay Support Program. However, this requires:

A prior authorization form submitted by your treating hematologist

Clinical documentation supporting medical necessity

Enrollment in HEMGENIX Connect for financial coordination

Starting this process now — even if supply is delayed — keeps you positioned to receive Hemgenix as quickly as possible once availability is confirmed.

What to Do If No Centers Near You Have Supply

If treatment centers in your area do not currently have Hemgenix in stock:

Ask your hematologist to check with their CSL Behring representative for regional supply updates

Inquire whether major academic medical centers in larger cities (e.g., Mayo Clinic, Johns Hopkins, University of Michigan) have supply and whether you can travel for treatment

Ask your HEMGENIX Connect Case Manager for the nearest center currently receiving shipments

For more background on why Hemgenix is hard to find, read Why Is Hemgenix So Hard to Find? Or use medfinder.com to search for available supply in your area today.